Get started
Author

Johannes H. Fruehauf

Short hairpin RNA–expressing bacteria elicit RNA interference in mammals
2006 · Shuanglin Xiang, Johannes Fruehauf, et al. · Nature Biotechnology · 271
Delivery of RNA Interference
2006 · Charles X Li, Amy Parker, et al. · Cell Cycle · 189
RNAi therapeutics: an update on delivery.
2008 · Thu Nguyen, Ellen M Menocal, et al. · PubMed · 111
Saccharomyces boulardii Inhibits EGF Receptor Signaling and Intestinal Tumor Growth in Apc Mice
2009 · Xinhua Chen, Johannes Fruehauf, et al. · Gastroenterology · 98
PDF
GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
2012 · Marc S. Raab, Iris Breitkreutz, et al. · Cancer Research · 68
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling
2008 · Marc S. Raab, Iris Breitkreutz, et al. · Blood · 65
PDF
High-intensity focused ultrasound for the targeted destruction of uterine tissues: experiences from a pilot study using a mobile HIFU unit
2007 · Johannes H. Fruehauf, Walter Back, et al. · Archives of Gynecology and Obstetrics · 49
Bacterial vectors and delivery systems in cancer therapy.
2010 · Roman Gardlik, Johannes H Fruehauf · PubMed · 46
Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cells
2009 · Andrea Kruehn, Aijin Wang, et al. · Cell Cycle · 25
In Vitro and In Vivo Gene Silencing by TransKingdom RNAi (tkRNAi)
2008 · Shuanglin Xiang, Andrew C. Keates, et al. · Methods in molecular biology · 19
Engineered E. coli as Vehicles for Targeted Therapeutics
2010 · Caitlin Buttaro, Johannes Fruehauf · Current Gene Therapy · 16
transkingdom RNA Interference (tkRNAi): A Novel Method to Induce Therapeutic Gene Silencing
2009 · Thu A. Nguyen, Johannes H. Fruehauf · Methods in molecular biology · 13
TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery
2008 · Andrew C. Keates, Johannes Fruehauf, et al. · Biotechnology and Genetic Engineering Reviews · 12
PDF
Genomic Instability in Precancerous Lesions before Inactivation of Tumor Suppressors p53 and APC in Patients
2006 · Youxin Yang, Johannes Fruehauf, et al. · Cell Cycle · 12
PDF
Research Spotlight: Delivery of Therapeutic RNA Molecules to Cancer Cells By Bacteria
2011 · Hermann Lage, Johannes H Fruehauf · Therapeutic Delivery · 10
Inhibiting avian influenza virus shedding using a novel RNAi antiviral vector technology: proof of concept in an avian cell model
2016 · Lyndsey M. Linke, Jeffrey Wilusz, et al. · AMB Express · 9
PDF
Cequent Pharmaceuticals, Inc.: The Biological Pitcher for RNAi Therapeutics
2007 · Andrew C Keates, Johannes H Fruehauf, et al. · Pharmacogenomics · 6
Targeting PKC: A Novel Role for Beta-catenin in ER Stress and Apoptotic Signaling
2008 · Marc S Raab, Iris Breitkreutz, et al. · Blood · 5
New perspectives on melanoma pathogenesis and chemoprevention
2006 · F.L. Meyskens, P. Farmer, et al. · European Journal of Cancer Supplements · 4
Life Science Incubation at LabCentral/BioLabs with Partners Extending from the USA to Europe
2024 · Johannes Fruehauf · Handbook of experimental pharmacology · 1
Transkingdom Rna Interference: a Bacterial Approach to Challenges in Rnai Therapy and Delivery
2012 · Andrew C. Keates, Johannes Fruehauf, et al. · Nottingham University Press eBooks · 1
565 Ind-Enabling Studies for CEQ508 Targeting β-Catenin of GI Polyps: First Oral RNAI Drug
2010 · Natalya Bodyak, Alex Borrelli, et al. · Gastroenterology · 1
Supplementary Figure Legends 1-5 from GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
2023 · Marc S. Raab, Iris Breitkreutz, et al.
PDF
Supplementary Figure 5 from GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
2023 · Marc S. Raab, Iris Breitkreutz, et al.
Supplementary Figure 3 from GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
2023 · Marc S. Raab, Iris Breitkreutz, et al.
Works count: 51
Citation count: 1,031
H-index: 12
I10-index: 15
Year
Topic
Type